RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

NCT01236586 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Lymphoma
Brain Neoplasms
Sarcoma
Osteosarcoma
Wilm's Tumor

Interventions

DRUG: RO4929097
DRUG: Dexamethasone

Sponsor

National Cancer Institute (NCI)